MA31145B1 - Composition antivirale et procede d'utilisation - Google Patents

Composition antivirale et procede d'utilisation

Info

Publication number
MA31145B1
MA31145B1 MA32065A MA32065A MA31145B1 MA 31145 B1 MA31145 B1 MA 31145B1 MA 32065 A MA32065 A MA 32065A MA 32065 A MA32065 A MA 32065A MA 31145 B1 MA31145 B1 MA 31145B1
Authority
MA
Morocco
Prior art keywords
antiviral composition
lambdacarrageenan
iota
kappa
prophylaxis
Prior art date
Application number
MA32065A
Other languages
English (en)
Inventor
Andreas Grassauer
Christiane Meier
Eva Prieschl-Grassauer
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Priority claimed from EP06450176A external-priority patent/EP1930015A1/fr
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of MA31145B1 publication Critical patent/MA31145B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

La présente invention porte sur l'utilisation de iota-, kappa- ou lambdacarragénine ou des mélanges de celles-ci pour la fabrication d'une composition pharmaceutique antivirale utile dans la prophylaxie ou le traitement d'une infection rhinovirale.
MA32065A 2006-12-05 2009-07-02 Composition antivirale et procede d'utilisation MA31145B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
EP06450176A EP1930015A1 (fr) 2006-12-05 2006-12-05 Utilisation de carraghénine pour traiter les infections causées par le rhinovirus

Publications (1)

Publication Number Publication Date
MA31145B1 true MA31145B1 (fr) 2010-02-01

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32065A MA31145B1 (fr) 2006-12-05 2009-07-02 Composition antivirale et procede d'utilisation

Country Status (24)

Country Link
EP (1) EP2101792B1 (fr)
JP (1) JP5470047B2 (fr)
KR (1) KR101437708B1 (fr)
CN (1) CN101678040B (fr)
AT (1) ATE462438T1 (fr)
AU (1) AU2007327934B2 (fr)
BR (1) BRPI0720054A2 (fr)
CA (1) CA2671317C (fr)
CY (1) CY1110658T1 (fr)
DE (1) DE602007005697D1 (fr)
DK (1) DK2101792T3 (fr)
EA (1) EA015930B1 (fr)
ES (1) ES2343701T3 (fr)
HK (1) HK1141980A1 (fr)
IL (1) IL198810A (fr)
MA (1) MA31145B1 (fr)
MX (1) MX2009005838A (fr)
NO (1) NO342681B1 (fr)
NZ (1) NZ577063A (fr)
PL (1) PL2101792T3 (fr)
PT (1) PT2101792E (fr)
SI (1) SI2101792T1 (fr)
TN (1) TN2009000211A1 (fr)
WO (1) WO2008067982A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065869B (zh) * 2008-07-01 2014-10-08 玛丽诺姆德生物技术公司 抗过敏的海洋生物聚合物
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
CN102652017A (zh) 2009-12-22 2012-08-29 玛丽诺姆德生物技术公司 协同抗病毒组合物及其应用
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
PT2898888T (pt) * 2014-01-22 2019-07-16 Visufarma B V Composição que compreende iota-carragenina contra conjuntivite viral
PT3370692T (pt) 2015-07-14 2023-07-18 Marinomed Biotech Ag Composição que elimina a congestão nasal e possui atividade antiviral
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
KR20230094472A (ko) * 2021-12-21 2023-06-28 (주)메디코어 비강 세정제 조성물 및 그 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505046A (ja) 2000-07-28 2004-02-19 イムファルム・アンパルトセルスカブ 感冒、アレルギー性鼻炎および気道に関連した感染症の症状の処置方法
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
WO2003093322A2 (fr) * 2002-04-30 2003-11-13 The Population Council, Inc. Formulations ameliorees de polysaccharide sulfate, leurs procedes, preparations et utilisations
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN101385741B (zh) * 2003-05-26 2012-05-16 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
WO2006003521A1 (fr) * 2004-02-06 2006-01-12 Monash University Utilisation a haute dose et sur un intervalle court de polysaccharides sulfates dans le traitement des infections
DE202005014019U1 (de) * 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
MX2009005838A (es) 2009-06-16
NO20091955L (no) 2009-09-04
IL198810A (en) 2013-03-24
NZ577063A (en) 2011-05-27
EA015930B1 (ru) 2011-12-30
WO2008067982A2 (fr) 2008-06-12
CN101678040A (zh) 2010-03-24
HK1141980A1 (en) 2010-11-26
EP2101792B1 (fr) 2010-03-31
PL2101792T3 (pl) 2010-11-30
DE602007005697D1 (de) 2010-05-12
PT2101792E (pt) 2010-06-25
EA200970529A1 (ru) 2009-12-30
CA2671317A1 (fr) 2008-06-12
DK2101792T3 (da) 2010-07-26
CA2671317C (fr) 2015-03-17
SI2101792T1 (sl) 2010-08-31
KR101437708B1 (ko) 2014-09-03
WO2008067982A3 (fr) 2009-04-16
EP2101792A2 (fr) 2009-09-23
JP5470047B2 (ja) 2014-04-16
IL198810A0 (en) 2010-02-17
KR20090096598A (ko) 2009-09-11
BRPI0720054A2 (pt) 2013-12-17
ATE462438T1 (de) 2010-04-15
AU2007327934A1 (en) 2008-06-12
TN2009000211A1 (en) 2010-10-18
CY1110658T1 (el) 2015-06-10
JP2010512307A (ja) 2010-04-22
NO342681B1 (no) 2018-07-02
AU2007327934B2 (en) 2013-04-18
CN101678040B (zh) 2012-10-03
ES2343701T3 (es) 2010-08-06

Similar Documents

Publication Publication Date Title
MA31145B1 (fr) Composition antivirale et procede d'utilisation
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
CY1111437T1 (el) Τετραϋδροπυρρολοπυριμιδινοδιονες και η χρηση τους ως αναστολεων της ανθρωπινης ουδετεροφιλης ελαστασης
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
MX2010002296A (es) Inhibidores iv de polimerasa de fosfadiazina hcv.
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze
AR046245A1 (es) Sales de calcio de rabeprazol
FR2916437B1 (fr) Procede de traitement bacterien d'effluents contenant du 2-ethylhexyl nitrate.
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
ATE424834T1 (de) Zellulosesulfat zur behandlung von rhinovirus- infektionen
UA39498U (ru) Способ лечения системной красной волчанки
ATE482198T1 (de) Sitamaquintosylat zur behandlung von leishmaniase